Show simple item record

dc.contributor.authorBjerkeset, Ottar
dc.contributor.authorWilliams, Lana J
dc.contributor.authorBerk, Michael
dc.contributor.authorSund, Erik R
dc.contributor.authorSletvold, Hege
dc.contributor.authorBojanic, Ivana
dc.date.accessioned2022-10-24T11:51:09Z
dc.date.available2022-10-24T11:51:09Z
dc.date.created2022-07-19T18:28:05Z
dc.date.issued2022
dc.identifier.issn2199-1154
dc.identifier.urihttps://hdl.handle.net/11250/3027923
dc.description.abstractBackground Cardiovascular agents, including angiotensin-converting enzyme inhibitors, angiotensin II receptor inhibitors, acetylsalicylic acid, statins, and metformin, have demonstrated benefits for depression. However, there is scant evaluation of these drugs’ antidepressant properties in large population settings. Objective This study aimed to examine cross-sectional associations between depression symptoms and the use of cardiovascular agents and metformin in populations with cardiovascular diseases or diabetes mellitus. Methods Participants in the Trøndelag Health Study 2006–08 (HUNT3, n = 40,516) and 2017–19 (HUNT4, n = 42,103) were included and data on their drug use from 2006 to 2019 was retrieved from the Norwegian Prescription Database. The outcome was self-reported depression symptoms defined by the Hospital Anxiety and Depression Scale. Associations between cardiovascular agents or metformin use and self-reported depression were analyzed by multi-level logistic regression in sex-stratified samples. Results Among men with cardiovascular diseases, use of acetylsalicylic acid was associated with reduced depression symptoms compared with acetylsalicylic acid non-users (reference) in HUNT3 and HUNT4 [risk ratio = 0.76; 95% confidence interval 0.59–0.94, risk ratio = 0.67; 95% CI 0.52–0.82, respectively]. Similarly, male statin users had a lower likelihood of reporting depression than statin non-users in HUNT3 (risk ratio = 0.70; 95% confidence interval 0.54–0.86) and HUNT4 (risk ratio = 0.67; 95% confidence interval 0.51–0.84). Associations between statins or acetylsalicylic acid use and reduced depression symptoms were detected in women with cardiovascular diseases in HUNT4. We found no statistical support for associations between other cardiovascular agents or metformin use and a reduced or increased depression symptom risk. Conclusions Results suggest negative associations between acetylsalicylic acid or statin use and depression symptoms. However, longitudinal cohort studies and randomized controlled trials are required to confirm the antidepressant effects of these drugs.en_US
dc.language.isoengen_US
dc.publisherSpringeren_US
dc.rightsNavngivelse-Ikkekommersiell 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/deed.no*
dc.titleAssociations of Cardiovascular Agents and Metformin with Depression Symptoms: A Cross-Sectional Analysis from the HUNT Study, Norwayen_US
dc.title.alternativeAssociations of Cardiovascular Agents and Metformin with Depression Symptoms: A Cross-Sectional Analysis from the HUNT Study, Norwayen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.source.journalDrugs - real world outcomesen_US
dc.identifier.doi10.1007/s40801-022-00321-7
dc.identifier.cristin2038815
cristin.ispublishedtrue
cristin.fulltextpostprint
cristin.qualitycode1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse-Ikkekommersiell 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse-Ikkekommersiell 4.0 Internasjonal